Health Technology Innovations
Health Technology Innovations, Inc. (HTI) is a company specializing in accelerating structure-based drug discovery through advanced cryo-electron microscopy (cryo-EM) services and AI-driven software solutions. HTI offers fast, affordable, and scalable cryo-EM services that enable high-resolution 3D structure determination of biological macromolecules and drug targets, complementing traditional biophysical methods like X-ray crystallography and NMR. Their proprietary CryoDiscovery™ software automates cryo-EM image processing using machine learning, enhancing throughput and accuracy in single particle analysis. HTI also developed CryoFAST™, an AI data automation solution that integrates with leading cryo-EM platforms to speed data collection for pharmaceutical research. The company collaborates with academic, government, and industry partners, including pharmaceutical and biotech firms, and has received multiple innovation grants and a National Science Foundation Phase II award for its AI-based cryo-EM automation platform. HTI's leadership team includes experts in structural biology, drug discovery, AI, and engineering, positioning the company as a key player in the biotech and pharmaceutical research market.
Health Technology Innovations
Health Technology Innovations, Inc. (HTI) is a company specializing in accelerating structure-based drug discovery through advanced cryo-electron microscopy (cryo-EM) services and AI-driven software solutions. HTI offers fast, affordable, and scalable cryo-EM services that enable high-resolution 3D structure determination of biological macromolecules and drug targets, complementing traditional biophysical methods like X-ray crystallography and NMR. Their proprietary CryoDiscovery™ software automates cryo-EM image processing using machine learning, enhancing throughput and accuracy in single particle analysis. HTI also developed CryoFAST™, an AI data automation solution that integrates with leading cryo-EM platforms to speed data collection for pharmaceutical research. The company collaborates with academic, government, and industry partners, including pharmaceutical and biotech firms, and has received multiple innovation grants and a National Science Foundation Phase II award for its AI-based cryo-EM automation platform. HTI's leadership team includes experts in structural biology, drug discovery, AI, and engineering, positioning the company as a key player in the biotech and pharmaceutical research market.